ClearNote Health will be showcasing the latest advancements in tumor subtyping and circulating tumor fraction technologies at the American Association for Cancer Research Annual Meeting 2025. “ClearNote Health is looking forward to updating the AACR community about the significant progress we’ve made in empowering drug development through epigenomics,” said Gulfem D. Guler. PhD, Vice President of Translational Research and Head of Biopharma Development at ClearNote Health. “Our proprietary Virtuoso™ epigenomics platform measures active disease biology and provides dynamic insights into drug response and resistance, all through a simple blood draw.” 👉 Learn more about Virtuoso or read about the presentations here: https://lnkd.in/dHPbBsib #epigenomics #drugdevelopment
📢 Our team will be out in full force at the American Association for Cancer Research Annual Meeting 2025, April 25-30, 2025, taking place at the McCormick Place Convention Center, Chicago, Illinois. Discover how our Virtuoso Epigenomics Platform is empowering more efficient oncology drug discovery and development by leveraging 5hmC epigenomic profiling to uncover active cancer biology patterns from cfDNA in plasma. Don't miss our poster presentation and collaborator poster presentation to learn more: 🗒️ Title: 5hmC-sequencing of matched cfDNA and tissue from men with mCRPC is concordant and identifies loss of AR signaling in NEPC and DNPC Presenting author: Rensheng Wan (UCSF) Session Title: Liquid Biopsy: Circulating Tumor Cells 1 Session Start: 4/28/2025 9:00:00 AM Session End: 4/28/2025 12:00:00 PM Location: Poster Section 29 Poster Board Number: 20 Published Abstract Number: 1985 🗒️ Title: A tumor-naïve method for estimating tumor fraction using 5-hydroxymethylation cytosine in cell–free DNA Presenting author: Ceyda Coruh (ClearNote Health) Session Title: Convergence Science Diagnostic and Predictive Approaches Session Date and Time: Monday Apr 28, 2025 2:00 PM – 5:00 PM Location: Poster Section 46 Poster Board Number: 10 Published Abstract Number: 3681 👉 Reach out to schedule a meeting: [email protected] #LiquidBiopsy #Cancer #Epigenomics #Oncology
